Creo Medical Limited

LSE CREO.L

Creo Medical Limited Operating Income for the year ending December 31, 2023: USD -31.55 M

Creo Medical Limited Operating Income is USD -31.55 M for the year ending December 31, 2023, a 15.25% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.
  • Creo Medical Limited Operating Income for the year ending December 31, 2022 was USD -37.23 M, a 8.16% change year over year.
  • Creo Medical Limited Operating Income for the year ending December 31, 2021 was USD -40.54 M, a -26.91% change year over year.
  • Creo Medical Limited Operating Income for the year ending December 31, 2020 was USD -31.94 M, a -26.77% change year over year.
  • Creo Medical Limited Operating Income for the year ending December 31, 2019 was USD -25.20 M, a -65.65% change year over year.
Key data
Date Operating Income EBIT EBITDA Net Income
Market news
Loading...
SV Wall Street
LSE: CREO.L

Creo Medical Limited

CEO Mr. Craig Jonathan Gulliford
IPO Date Dec. 9, 2016
Location United Kingdom
Headquarters Unit 2, Creo House
Employees 278
Sector Health Care
Industries
Description

Creo Medical Limited engages in the research and development of electrosurgical medical devices relating to the field of surgical endoscopy in the United Kingdom. It is developing Croma, an energy platform that powers a suite of multi-modal devices to optimize treatments for patients and physicians. The company also offers Speedboat Inject, an energy multimodality instrument for flexible endoscopy; Speedboat Slim, a flexible bipolar RF and microwave device for cutting and coagulation; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a flexible microwave ablation device; SlypSeal Flex, a flexible haemostasis device for the treatment of upper and lower GI bleeds; and SpydrBlade Flex, a flexible bipolar RF and microwave scissor device that grasps, cuts and, coagulates highlyperfused tissues. Creo Medical Limited was formerly known as MicroOncology Ltd. The company was incorporated in 2003 and is headquartered in Chepstow, the United Kingdom. Creo Medical Limited is a subsidiary of Creo Medical Group plc.

Similar companies

APH.L

Alliance Pharma plc

USD 0.76

0.02%

RENX.L

Renalytix Plc

USD 0.13

0.02%

EKF.L

EKF Diagnostics Holdings plc

USD 0.31

-5.10%

AMS.L

Advanced Medical Solutions Group plc

USD 2.60

-0.46%

AGL.L

ANGLE plc

USD 0.19

13.23%

StockViz Staff

January 30, 2025

Any question? Send us an email